Paclitaxel is a cytotoxic chemotherapy drug being tested in
early clinical trials for its capacity to treat cancer. Phase I trials are
designed primarily to assess safety, tolerability, and dosing, rather than
efficacy.

Based on the goals of Phase I trials and the disease being targeted,
which population is MOST LIKELY to have been used initially?

Question

Paclitaxel is a cytotoxic chemotherapy drug being tested in
early clinical trials for its capacity to treat cancer. Phase I trials are
designed primarily to assess safety, tolerability, and dosing, rather than
efficacy.

Based on the goals of Phase I trials and the disease being targeted,
which population is MOST LIKELY to have been used initially?

Accepted Answer

a small number (50 – 100) of patients with the target disorder (cancer)

Answer

a small number (50 – 100) of healthy volunteers

Answer

200 – 400 patients with the target disorder (cancer)

Answer

200 – 400 healthy volunteers

Crowdly

Paclitaxel is a cytotoxic chemotherapy drug being tested in early clinical tria...

Want instant access to all verified answers on learning.monash.edu?